Skip to main content
Premium Trial:

Request an Annual Quote

Genome Quebec Buys One of Illumina s Integrated Genotyping Labs

NEW YORK, Jan. 9 - Genome Quebec has bought one of Illumina's nameless SNP-genotyping laboratories, the company said today.

 

The system, which will be located at the newly opened Genome Quebec Innovation Centre, will help the Canadian center contribute data to the International HapMap Project as well as research at Genome Quebec, Genome Canada, McGill University, and other academic centers in the country.

 

The product costs between $1.5 million and $2 million and comprises Sherlock scanning equipment, GoldenGate assay protocols, LIMS and analytical software, fluid-handling robotics, and access to Sentrix array matrices and reagent supply. When installed, the lab, which is at the center of a legal dispute with Applied Biosystems, will be able to crank out one million genotypes per day.

 

Click here for more information.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.